SMITH STAN purchased 4.4% of their position (50K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $75.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/25/2025ACC: 0001127602-25-006574
+100K
Net shares
Net buyer
$75.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+50K
Price / share
$1.50
Trade value
$75K
% of position
4.4%
2/24/2025
1.13M→1.18M
Total
Net shares
+50K
Net value
$75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/24/2025 | P · Purchase | +50K | $1.50 | $75K | 4.4% | 1.13M | 1.18M |
| Total | +50K | $75K | ||||||
Derivative Transactions1
Warrants
Indirect
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
1.87
Held after
50K
Exercisable
—
2/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock50K shares | 2/24/2025 | P · Purchase | +50K | 1.87 | — | 50K |